ABOUT BE BIOSOL
BE Biosol is the biologics CDMO business of Biological E. Limited, combining more than 70 years of biopharmaceutical manufacturing experience with a growing, integrated development and manufacturing platform for global biopharma partners.
With a strong track record supporting regulated markets and long-standing relationships with leading pharmaceutical companies, BE Biosol provides development, analytical, technology transfer, and commercial manufacturing solutions across biologics and vaccines.
Our established sterile drug product capabilities include liquid and lyophilized vials, prefilled syringes, and cartridges, supported by significant available capacity for new partner programs. BE Biosol is also investing in expanded drug substance, drug product, and R&D infrastructure to create an increasingly integrated development-to-commercial platform.
Backed by Biological E.’s global operating experience, quality culture, and manufacturing scale, BE Biosol offers partners a compelling combination of scientific expertise, reliable execution, competitive economics, and capacity available today.
Built on a legacy. Focused on your success.
CONTACT INFORMATION
BE Biosol
Biological E. Limited Road No. 35, Jubilee Hills Hyderabad
Telangana, 500033
INDIA
SOLUTIONS
-
![BE-Biosol-CPHI-OPCU]( "BE Biosol Capabilities Update August 2026: CPHI Special Edition")
BE BioSol is the biologics CDMO business of Biological E. Limited, combining more than 70 years of biopharmaceutical manufacturing experience with a growing, integrated development and manufacturing platform for global biopharma partners.
-
![right-cdmo-for-you-GettyImages-2228358677]( "End-To-End CDMO Capabilities")
BE Biosol provides integrated development and manufacturing services across biologics, vaccines and complex injectable products.
-
![Medical vaccine, injection medicine-GettyImages-1048358254]( "Accelerating Complex Injectable Programs")
Accelerate complex injectable development with integrated capabilities in lipid nanoparticles, liposomes, sterile products, and combination devices.
-
![Small interfering RNA, sirna, mrna, crispr-GettyImages-1409578453]( "Comprehensive ASO And siRNA Capabilities")
BE Biosol is expanding its biologics portfolio to include future capabilities in antisense oligonucleotide and siRNA technologies.
-
![GettyImages-1441786721 antibodies]( "From ADC Development To Commercial Readiness")
Designed for highly potent compounds, the platform supports ADC development from early-stage research through GMP manufacturing and commercial scale-up.
-
![mAb, monoclonal antibody, antigen, vaccine-GettyImages-2245122166]( "Supporting Monoclonal Antibody Success At Every Stage")
Scaling a monoclonal antibody program? Discover capabilities in development, purification, formulation, and GMP manufacturing across multiple scales.
-
![newest vaccine in laboratory-GettyImages-1225389179]( "Vaccine Development And Manufacturing")
Supplying products to 140+ countries and delivering billions of doses worldwide, Biosol provides integrated drug substance, drug product, fill-finish, and supply capabilities.
-
![quality control, sterile pharmaceutical manufacturing facility-GettyImages-2277115553]( "Manufacturing At Scale")
A multi-site manufacturing network supporting vaccines, biologics and specialty injectables—with significant infrastructure expansion planned through 2029.
-
![regulatory-biologics-GettyImages-1417312680]( "Regulatory Confidence At Every Stage")
Built on a foundation of quality, compliance, and operational excellence, our systems support your program from development through commercial supply across global regulatory markets.
